Latest News

Okta's Q1 release reveals AI disruption fears were overblown and demand remains strong—agentic AI drives accelerating need for ID security.

Cameco, BWX, and Oklo will all benefit from the expansion of the nuclear energy market.

The space flight competitor is falling while SpaceX is soaring.

Apple's entry into the foldable smartphone market could unlock a terrific growth opportunity for the tech giant.

The stock's year-to-date tumble is a clear disconnect from its fundamental growth.

With rate hike odds rising and cuts off the table, JPMorgan Chase, Enterprise Products Partners, and Berkshire Hathaway stand to benefit from a higher-for-longer rate environment.

Shareholders woke up to the idea that their company will have a new owner by the end of the year.

These two healthcare leaders have a long history of competing against one another.

If you're on the fence about diving into this name in the middle of the hype, this might help you sort out your decision.

The Dow and Nasdaq went opposite directions Tuesday. SpaceX and falling oil prices explain why.

On June 16, 2026, SpaceX’s AI deal reshaped Nasdaq leadership and intensified momentum around high‑growth tech.

The Vanguard S&P 500 Growth ETF is a solid idea for both long-term investors and those just starting out.

This clean energy stock just took a big step toward meeting its growing demand.

Five high-yield stocks — ET, JBS, DEC, CPA, and SFD — offer yields ranging from 4.8% to 8.8%, backed by bullish analyst sentiment and sustainable free cash flow.

Prateek Group has consistently set a high benchmark in Noida's real estate landscape, delivering homes that go beyond four walls and a roof. For families s

IntroductionIn today's social media-driven world, memes and humor have become powerful marketing tools for businesses looking to increase engagement and co

Vanguard Dividend Appreciation and Fidelity High Dividend are among the two top dividend ETFs to buy. Here's how to decide which one to pick.

The top "pure play" in hydrogen power still has a bright future.

IntroductionIn 2026, customers expect brands to understand their needs and deliver relevant experiences at every stage of their buying journey. Generic mar

The company has repeatedly expanded with great success. Now, Axon is doing it again.

IInfotanks has helped B2B marketers across pharmaceuticals, medical devices, healthcare IT, clinical research, and health education understand that expandi

What Happened? Shares of business intelligence platform Domo (NASDAQ:DOMO) fell 35.7% in the afternoon session after the company reported Q1 FY2027 results t...

Explore how each fund's unique approach to portfolio construction and risk management could impact your fixed income strategy.

CarMax is exiting a buy zone as a key rival looks to disrupt auto sales again.

Investors have rushed to get in on this tech and industrial giant.